• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Incyte Corp Ltd

+ Add to Watchlist


35.590 EUR 0.035 0.10%

As of 03:21:20 ET on 07/25/2014.

Snapshot for Incyte Corp Ltd (ICY)

Open: 35.271 Day's Range: 35.250 - 35.590 Volume: 0
Previous Close: 35.555 52wk Range: 17.300 - 51.004 1-Yr Rtn: +105.84%

Stock Chart for ICY

No chart data available.
  • ICY:GR 35.590
  • 1D
  • 1M
  • 1Y
Interactive ICY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ICY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4220
Est. PEG Ratio -
Market Cap (M EUR) 5,965.88
Shares Outstanding (M) 167.63
30 Day Average Volume 115
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ICY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ICY

Incyte Corporation is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. The Company has drug discovery programs underway focused on the identification of new small molecule drugs for cancer and inflammation.

Herve HoppenotPresident/CEODavid C HastingsExec VP/CFO
James M Daly "Jim"Exec VP/Chief Commercial OfcrRichard S LevyExec VP/Chief Drug Dev & Medical Ofcr
More Company Profile & Key Executives for ICY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil